Half-Life Extension by Binding to Albumin through an Albumin Binding Domain

Therapeutic Proteins: Strategies to Modulate Their Plasma Half-Lives

Volumn , Issue , 2012, Pages 269-283

  Frejd, Fredrik Y ^a,b  

^a Affibody AB   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

ADB; Albumin binding domain; FcRn; Half life extension; Immunogenicity; Neonatal Fc receptor; Therapeutic proteins

Indexed keywords

EID: 84886143165     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527644827.ch14     Document Type: Chapter

References (55)

1. Andersen, J.T., Pehrson, R., Tolmachev, V., Daba Bekele, M., Abrahmsén, L., Sandlie, I., and Ekblad, C.(2011)Extending half-life by indirect targeting of the neonatal Fc receptor (FcRn) using a minimal albumin binding domain (ABD). J. Biol. Chem., 286, 5234-5241. Epub 2010 Dec 7, 10.1074/jbc.M110.164848.
2. Nygren, P.A., Uhlen, M., Flodby, P., Andersson, R., and Wigzell, H.(1991)In vivo stabilization of a human recombinant CD4 derivative by fusion to a serum-albumin-binding receptor, in Vaccines 91 (eds R.M. Chanock, H.S. Ginsberg, F. Brown, and R.A. Lerner), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 363-368.
3. Smith, B.J., Popplewell, A., Athwal, D., Chapman, A.P., Heywood, S., West, S.M., Carrington, B., Nesbitt, A., Lawson, A.D., Antoniw, P., Eddelston, A., and Suitters, A.(2001)Prolonged in vivo residence times of antibody fragments associated with albumin. Bioconjug. Chem., 12(5), 750-756.
4. Holt, L.J., Basran, A., Jones, K., Chorlton, J., Jespers, L.S., Brewis, N.D., and Tomlinson, I.M. (2008) Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs. Protein Eng. Des. Sel., 21 (5), 283-288. Epub 2008 Apr 2.
5. Roovers, R.C., Laeremans, T., Huang, L., De Taeye, S., Verkleij, A.J., Revets, H., de Haard, H.J., and van Bergen en Henegouwen, P.M. (2007) Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR nanobodies. Cancer Immunol. Immunother., 56(3), 303-317.
6. Dennis, M.S., Zhang, M., Meng, Y.G., Kadkhodayan, M., Kirchhofer, D., Combs, D., and Damico, L.A. (2002) Albumin binding as a general strategy for improving the pharmacokinetics of proteins. J. Biol. Chem., 277 (38), 35035-35043. Epub 2002 Jul 15.
7. Nguyen, A., Reyes, A.E. 2nd, Zhang, M., McDonald, P., Wong, W.L., Damico, L.A., and Dennis, M.S. (2006) The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin. Protein Eng. Des. Sel., 19 (7), 291-297. Epub 2006 Apr 18.
8. Kronvall, G., Simmons, A., Myhre, E.B., and Jonsson, S.(1979)Specific absorption of human serum albumin, immunoglobulin A, and immunoglobulin G with selected strains of group A and G streptococci. Infect. Immun. 25(1), 1-10.
9. Myhre, E.B., and Kronvall, G. (1980) Demonstration of specific binding sites for human serum albumin in group C and G streptococci. Infect. Immun. 27(1), 6-14.
10. Forsgren, A., and Sjöquist, J. (1966) "Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin. J. Immunol. 97 (6), 822-827.
11. Langone, J.J. (1982) Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci. Adv. Immunol., 32, 157-252. Review.
12. Björck, L., Kastern, W., Lindahl, G., and Widebäck, K. (1987) Streptococcal protein G, expressed by streptococci or by Escherichia coli, has separate binding sites for human albumin and IgG. Mol. Immunol., 24 (10), 1113-1122.
13. Nygren, P.A., Ljungquist, C., Trømborg, H., Nustad, K., and Uhlén, M. (1990) Species-dependent binding of serum albumins to the streptococcal receptor protein G. Eur. J. Biochem., 193 (1), 143-148.
14. Fahnestock, S.R., Alexander, P., Nagle, J., and Filpula, D. (1986) Gene for an immunoglobulin-binding protein from a group G streptococcus. J. Bacteriol., 167 (3), 870-880.
15. Guss, B., Eliasson, M., Olsson, A., Uhlén, M., Frej, A.K., Jörnvall, H., Flock, J.I., and Lindberg, M. (1986) Structure of the IgG-binding regions of streptococcal protein G. EMBO J., 5 (7), 1567-1575.
16. Akerström, B., Nielsen, E., and Björck, L. (1987) Definition of IgG-and albumin-binding regions of streptococcal protein G. J. Biol. Chem., 262 (28), 13388-13391.
17. Olsson, A., Eliasson, M., Guss, B., Nilsson, B., Hellman, U., Lindberg, M., and Uhlén, M. (1987) Structure and evolution of the repetitive gene encoding streptococcal protein G. Eur. J. Biochem., 168 (2), 319-324.
18. Nygren, P.A., Eliasson, M., Abrahmsén, L., Uhlén, M., and Palmcrantz, E. (1988) Analysis and use of the serum albumin binding domains of streptococcal protein G. J. Mol. Recognit. Apr; 1 (2), 69-74.
19. Sjölander, A., Nygren, P.A., Stahl, S., Berzins, K., Uhlen, M., Perlmann, P., and Andersson, R. (1997) The serum albumin-binding region of streptococcal protein G: a bacterial fusion partner with carrier-related properties. J. Immunol. Methods, 201 (1), 115-123.
20. Nilsson, J., Larsson, M., Ståhl, S., Nygren, P.A., and Uhlén, M. (1996) Multiple affinity domains for the detection, purification and immobilization of recombinant proteins. J. Mol. Recognit., 9 (5-6), 585-594.
21. Nilsson, J., Ståhl, S., Lundeberg, J., Uhlén, M., and Nygren, P.A.(1997)Affinity fusion strategies for detection, purification, and immobilization of recombinant proteins. Protein Expr. Purif., 11(1), 1-16.
22. Rozak, D.A., Alexander, P.A., He, Y., Chen, Y., Orban, J., and Bryan, P.N. (2006) Using offset recombinant polymerase chain reaction to identify functional determinants in a common family of bacterial albumin binding domains. Biochemistry, 45 (10), 3263-3271.
23. Johansson, M.U., de Château, M., Wikström, M., Forsén, S., Drakenberg, T., and Björck, L. (1997) Solution structure of the albumin-binding GA module: a versatile bacterial protein domain. J. Mol. Biol., 266(5), 859-865.
24. Johansson, M.U., Frick, I.M., Nilsson, H., Kraulis, P.J., Hober, S., Jonasson, P., Linhult, M., Nygren, P.A., Uhlén, M., Björck, L., Drakenberg, T., Forsén, S., and Wikström, M.(2002)Structure, specificity, and mode of interaction for bacterial albumin-binding modules. J. Biol. Chem., 277(10), 8114-8120. Epub 2001 Dec 18.
25. Kraulis, P.J., Jonasson, P., Nygren, P.A., Uhlén, M., Jendeberg, L., Nilsson, B., and Kördel, J. (1996) The serum albumin-binding domain of streptococcal protein G is a three-helical bundle: a heteronuclear NMR study. FEBS Lett., 378 (2), 190-194.
26. Linhult, M., Binz, H.K., Uhlén, M., and Hober, S. (2002) Mutational analysis of the interaction between albumin-binding domain from streptococcal protein G and human serum albumin. Protein Sci., 11 (2), 206-213.
27. Lejon, S., Frick, I.M., Björck, L., Wikström, M., and Svensson, S. (2004) Crystal structure and biological implications of a bacterial albumin binding module in complex with human serum albumin. J. Biol. Chem., 279 (41), 42924-42928. Epub 2004 Jul 21.
28. Anderson, C.L., Chaudhury, C., Kim, J., Bronson, C.L., Wani, M.A., and Mohanty, S. (2006) Perspective-FcRn transports albumin: relevance to immunology and medicine. Trends Immunol., 27 (7), 343-348. Epub 2006 May 30. Review.
29. Chaudhury, C., Brooks, C.L., Carter, D.C., Robinson, J.M., and Anderson, C.L. (2006) Albumin binding to FcRn: distinct from the FcRn-IgG interaction. Biochemistry, 45 (15), 4983-4990.
30. Jonsson, A., Dogan, J., Herne, N., Abrahmsén, L., and Nygren, P.A. (2008) Engineering of a femtomolar affinity binding protein to human serum albumin. Protein Eng. Des. Sel., 21 (8), 515-527. Epub 2008 May 22.
31. Hopp, J., Hornig, N., Zettlitz, K.A., Schwarz, A., Fuss, N., Müller, D., and Kontermann, R.E. (2010) The effects of affinity and valency of an albumin-binding domain (ABD) on the half-life of a single-chain diabody-ABD fusion protein. Protein Eng. Des. Sel., 23 (11), 827-834. Epub 2010 Sep 3.
32. Goetsch, L., Haeuw, J.F., Champion, T., Lacheny, C., N'Guyen, T., Beck, A., and Corvaia, N. (2003) Identification of B-and T-cell epitopes of BB, a carrier protein derived from the G protein of Streptococcus strain G148. Clin. Diagn. Lab. Immunol., 10 (1), 125-132.
33. Makrides, S.C., Nygren, P.A., Andrews, B., Ford, P.J., Evans, K.S., Hayman, E.G., Adari, H., Uhlén, M., and Toth, C.A. (1996) Extended in vivo half-life of human soluble complement receptor type 1 fused to a serum albumin-binding receptor. J. Pharmacol. Exp. Ther., 277 (1), 534-542.
34. Nord, K., Nilsson, J., Nilsson, B., Uhlén, M., and Nygren, P.A. (1995) A combinatorial library of an alpha-helical bacterial receptor domain. Protein Eng., 8 (6), 601-608.
35. König, T., and Skerra, A. (1998) Use of an albumin-binding domain for the selective immobilisation of recombinant capture antibody fragments on ELISA plates. J. Immunol. Methods, 218 (1-2), 73-83.
36. Schlapschy, M., Theobald, I., Mack, H., Schottelius, M., Wester, H.J., and Skerra, A. (2007) Fusion of a recombinant antibody fragment with a homo-amino-acid polymer: effects on biophysical properties and prolonged plasma half-life. Protein Eng. Des. Sel. 20 (6), 273-284. Epub 2007 Jun 26.
37. Stork, R., Müller, D., and Kontermann, R.E.(2007)A novel tri-functional antibody fusion protein with improved pharmacokinetic properties generated by fusing a bispecific single-chain diabody with an albumin-binding domain from streptococcal protein G. Protein Eng. Des. Sel., 20(11), 569-576. Epub 2007 Nov 3.
38. Stork, R., Campigna, E., Robert, B., Müller, D., and Kontermann, R.E. (2009) Biodistribution of a bispecific single-chain diabody and its half-life extended derivatives. J. Biol. Chem., 284 (38), 25612-25619. Epub 2009 Jul 23.
39. Stork, R., Zettlitz, K.A., Müller, D., Rether, M., Hanisch, F.G., and Kontermann, R.E. (2008) N-glycosylation as novel strategy to improve pharmacokinetic properties of bispecific single-chain diabodies. J. Biol. Chem., 283 (12), 7804-7812. Epub 2008 Jan 22.
40. Goldblum, S.E., Ding, X., Funk, S.E., and Sage, E.H. (1994) SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. Proc. Natl. Acad. Sci. U.S.A., 91 (8), 3448-3452.
41. Tiruppathi, C., Song, W., Bergenfeldt, M., Sass, P., and Malik, A.B. (1997) Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J. Biol. Chem., 272 (41), 25968-25975.
42. Maeda, H., Wu, J., Sawa, T., Matsumura, Y., and Hori, K. (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release., 65 (1-2), 271-284. Review.
43. Ballantyne, F.C., Fleck, A., and Dick, W.C. (1971) Albumin metabolism in rheumatoid arthritis. Ann. Rheum. Dis., 30(3), 265-270.
44. Kratz, F. (2008) Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J. Control. Release, 132 (3), 171-183. Epub 2008 May 17. Review.
45. Orlova, A., Magnusson, M., Eriksson, T.L., Nilsson, M., Larsson, B., Höidén-Guthenberg, I., Widström, C., Carlsson, J., Tolmachev, V., Ståhl, S., and Nilsson, F.Y. (2006) Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res., 66 (8), 4339-4348.
46. Löfblom, J., Feldwisch, J., Tolmachev, V., Carlsson, J., Ståhl, S., and Frejd, F.Y. (2010) Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. FEBS Lett., 584 (12), 2670-2680. Epub 2010 Apr 11. Review.
47. Baum, R.P., Prasad, V., Müller, D., Schuchardt, C., Orlova, A., Wennborg, A., Tolmachev, V., and Feldwisch, J. (2010) Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In-or 68Ga-labeled affibody molecules. J. Nucl. Med., 51 (6), 892-897. Epub 2010 May 19.
48. Tolmachev, V., Orlova, A., Pehrson, R., Galli, J., Baastrup, B., Andersson, K., Sandström, M., Rosik, D., Carlsson, J., Lundqvist, H., Wennborg, A., and Nilsson, F.Y. (2007) Radionuclide therapy of HER2-positive microxenografts using a 177 Lu-labeled HER2-specific Affibody molecule. Cancer Res., 67 (6), 2773-2782.
49. Sjölander, A., Stahl, S., and Perlmann, P. (1993) Bacterial expression systems based on protein A and protein G designed for the production of immunogens: Applications to Plasmodium falciparum malara antigens. Immunomethods, 2, 79-92.
50. Libon, C., Corvaïa, N., Haeuw, J.F., Nguyen, T.N., Ståhl, S., Bonnefoy, J.Y., and Andreoni, C. (1999 )The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130-230 RSV-A protein. Vaccine, 17 (5), 406-414.
51. Power, U.F., Nguyen, T.N., Rietveld, E., de Swart, R.L., Groen, J., Osterhaus, A.D., de Groot, R., Corvaia, N., Beck, A., Bouveret-Le-Cam, N., and Bonnefoy, J.Y. (2001) Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults. J. Infect. Dis., 184 (11), 1456-1460. Epub 2001 Nov 13.
52. Ahlgren, S., Orlova, A., Wållberg, H., Hansson, M., Sandström, M., Lewsley, R., Wennborg, A., Abrahmsén, L., Tolmachev, V., and Feldwisch, J. (2010) Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffold. J. Nucl. Med., 51 (7), 1131-1138. Epub 2010 Jun 16.
53. Alm, T., Yderland, L., Nilvebrant, J., Halldin, A., and Hober, S. (2010) A small bispecific protein selected for orthogonal affinity purification. Biotechnol. J., 5 (6), 605-617.
54. Gülich, S., Linhult, M., Nygren, P., Uhlén, M., and Hober, S. (2000) Stability towards alkaline conditions can be engineered into a protein ligand. J. Biotechnol., 80 (2), 169-178.
55. Nilvebrant, J., Alm, T., Hober, S., and Löfblom, J. (2011) Engineering bispecificity into a single albumin binding domain. PLoS One. 6 (10), e25791. Epub 2011 Oct 3.